Jian Yan
Company: Personalis
Job title: Vice President - Research and Discovery
Seminars:
Use of ctDNA analysis to complement objective responses detected in patients with advanced HCC treated with GT-EPICâ„¢ based personalized cancer vaccines 10:00 am
Highlighting clinical response data from GNOS-PV02 Phase 1b/2a clinical trial in 2L advanced HCC Use of NeXT Personal® platform (Personalis, Inc.) to longitudinally monitor molecular residual disease (MRD) In a retrospective analysis of patient samples, ultrasensitive tumor informed ctDNA panel identified molecular responses in patients ahead of detection of partial responses (PR) and complete responses…Read more
day: Conference Day One